TABLE II. Genotoxicity, mutagenicity and mutagenic potency slope of nitroimidazoles 13, 16, 17 and 18.
Compound | Genotoxicity | Ames test (MI > 2) - Mutagenicity | Mutagenic potency slope (revertants/µg) | ||||||
---|---|---|---|---|---|---|---|---|---|
1,562 µM | 250 µM | 1,250 µM | 2,500 µM | TA97 | TA98 | TA100 | TA102 | TA1535 | |
13 | 1 (300 TAU) | - | TA100 | TA100 | 0.30 ± 0.22 | NA | 8.98 ± 0.71 | NA | NA |
16 | 0 (10 TAU) | - | TA100 | TA100 | NA | NA | 6.60 ± 0.63 | NA | NA |
17 | 3 (411 TAU) | TA100 | TA100 | TA98, TA100 | NA | 0.55 ± 0.08 | 41.70 ± 3.71 | 2.51 ± 0.44 | NA |
18 | 0 (32 TAU) | - | TA100 | TA98, TA100, TA102, TA1535 | 2.13 ± 0.14 | 0.69 ± 0.05 | 8.18 ± 0.15 | NA | 0.51 ± 0.07 |
MI: mutagenicity inde; NA: not applicable; TAU: total arbitrary units for the positive control, methyl methane-sulfonate value was 454.3 ± 9.2.